Clinical Trial Update: Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer

View source ↗

Summary

A clinical trial investigating molecular and epidemiological risk factors for gastric cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Gastric Cancer | Status: TERMINATED